Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Revenue

• Revenue (ttm): n/a
• Revenue Growth: n/a
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: 35
• Market Cap: 340.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	260.50K	137.06K	111.03%
Dec 31, 2022	123.44K	-2.98M	-96.02%
Dec 31, 2021	3.10M	2.40M	343.92%
Dec 31, 2020	698.47K	-424.27K	-37.79%
Dec 31, 2019	1.12M	-2.92M	-72.22%
Dec 31, 2018	4.04M	1.98M	96.07%
Dec 31, 2017	2.06M	1.09M	113.04%
Dec 31, 2016	967.39K	-	-

Data Source: Fiscal.ai Last updated: Mar 26, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error